Simmaron Research Inc. is a 501c3 non-profit organization based in Incline Village, Nevada. Our work advances translational science in treating neuroimmune diseases like CFS/ME. Translational science is the combination of research findings and clinical experience. The application of translational science makes possible enhanced clinician techniques and ultimately improves the quality of life for people suffering from CFS/ME and related neuroimmune disorders.
To help fund and conduct pilot studies to determine diagnostic markers and potential treatments for CFS/ME.
To openly share our findings with the scientific and medical communities to help develop translational science that ultimately improves the quality of life for people suffering from CFS/ME.
The Simmaron Research Story
The Simmaron story takes inspiration from the medical practice and leadership of Daniel L. Peterson, M.D., who has been caring for CFS/ME patients for more than a quarter of a century. Dr. Peterson, a member of Simmaron’s Scientific Advisory Board, has run an internal medicine practice located in Incline Village, Nevada for over 30 years.
Dr. Peterson’s interest in CFS/ME began in 1984 when Incline Village became the site of an unusual cluster of individuals presenting with unexplained flu-like symptoms that would not go away. Many of those individuals remained bedridden for extended periods of time. Dr. Peterson was perhaps the first to recognize these symptoms as something deserving of more attention.
Although his earliest calls to the U.S. Centers for Disease Control (CDC) went largely unanswered, Dr. Peterson did not give up. His compassion for and dedication to his patients drove him to continue to pursue answers about this mysterious illness, which would eventually be named chronic fatigue syndrome (CFS).
Dr. Peterson’s dedication coupled with his curiosity led him to collect biological samples from patients and keep detailed data files. Thanks to Dr. Peterson’s foresight, we now have access to a rich repository of biological samples and data records.
Building upon the wealth of knowledge and data Dr. Peterson has gathered and the internationally recognized scientists eager to collaborate, Simmaron was formed to raise funds to advance scientific research which holds the potential to improve treatment and care for individuals suffering from chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), and other immune dysfunction diseases.
Simmaron’s Goal: To Scientifically Redefine ME/CFS
Collaborate with leading scientists and clinicians to study well-documented immunological dysregulation in CFS/ME and neuroimmune disease.
Enable leading scientists in the fields of immunology, virology, exercise physiology and genetics to study well-characterized CFS/ME patient populations against controls.
Discover the reasons for increased incidence of immune system abnormalities such as low natural killer cell function, reactivated viral infection, elevated cytokine levels, elevated autoantibodies, and certain forms of cancer.
Hasten the identification of the causes, biomarkers and potential new treatments for this debilitating chronic illness.